Skye Bioscience Faces Class Action Lawsuit for Misleading Investors Under Securities Law

Class Action Lawsuit Against Skye Bioscience Inc.

The DJS Law Group has announced that investors of Skye Bioscience, Inc. (NASDAQ: SKYE) are faced with a class action lawsuit due to alleged violations of securities laws. This legal action particularly points to violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 which has been established by the U.S. Securities and Exchange Commission (SEC).

Background of the Case

The class period for this lawsuit spans from November 4, 2024, to October 3, 2025. During this time, shareholders who acquired SKYE shares are being encouraged to connect with DJS Law Group to potentially become lead plaintiffs. It's crucial to note that being designated as a lead plaintiff is not a prerequisite for participating in any recovery resultant from this lawsuit.

According to the complaint filed, Skye Bioscience is accused of disseminating inaccurate and deceptive statements to investors, particularly regarding the efficacy of its product nimacimab. The Company purportedly overstated nimacimab's capabilities, which were later revealed to be unsubstantiated. Consequently, these misrepresentations had the effect of misleading shareholders and creating a false impression about the company's financial stability and prospects.

Implications for Shareholders

For those who feel they incurred losses as a result of these misleading claims, taking the necessary steps to register as a shareholder during the specified class period is imperative. The DJS Law Group will provide these shareholders with monitoring software designed to keep them informed about the ongoing case's developments. Participation in this class action involves no financial burden or obligation for the shareholders and is intended to support those seeking recovery of their losses.

Why Engage DJS Law Group?

The DJS Law Group is recognized for its commitment to maximizing investor returns. By offering dedicated guidance and strong representation, the firm specializes in various legal cases including securities class actions and corporate governance disputes. With a clientele comprising top-tier hedge funds and asset managers, DJS Law Group emphasizes the importance of protecting investors' rights vigorously.

Next Steps for Interested Shareholders

Shareholders who believe they have been affected by these events are encouraged to connect with DJS Law Group promptly. The deadline for filing claims is set for January 16, 2026, highlighting the urgency for affected investors to act swiftly and protect their interests. Joining the lawsuit not only increases the chances of recovering losses but also holds the company accountable for its actions.

As developments unfold, the DJS Law Group remains dedicated to offering updates and strategic guidance to aid investors in navigating this challenging situation effectively.

For further inquiries or to join the case, shareholders can reach out to:

David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

Stay informed and protect your rights as a shareholder during this critical time.